http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PT-100256-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 |
filingDate | 1992-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_743c033b5b425bbab349ceaa348d53a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fb8a8ff9c15a49d5d22f8d55d885da6 |
publicationDate | 1999-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | PT-100256-B |
titleOfInvention | METHOD FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA |
abstract | The present invention relates to a method for the treatment of benign prostatic hyperplasia in men (BPH). It is characterized by involving combined therapy with a 5α-reductase inhibitor, for example 17β- substituted 4-azasteroids, 17β-substituted non- azasteroids, 17β-acyl-3-carboxy-androst-3,5-dienes, benzoylaminophenoxy butanoic acid derivatives, cinnamoylamide derivatives, condensed benzo(thio)amides, aromatic 1,2-diethers or thioethers, aromatic alkanoic ortho-acylaminophenoxy acids, aromatic ortho- thioalkylacylaminophenoxyalkanoic acids or pharmaceutically acceptable salts or esters thereof, and particularly finasteride in combination with an α1- adrenergic receptor blocker, for example terazosin. The combination provides a therapy at molecular level for the underlying cause of the disease, as well as relief of symptoms. Pharmaceutical compositions that are useful in said method of treatment are also disclosed. |
priorityDate | 1991-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1253.